日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of Chemotherapy Following Prior PARP-Inhibitor Treatment in Patients with Ovarian Cancer

卵巢癌患者既往接受过PARP抑制剂治疗后化疗的疗效

Kim, Jung Chul; Park, Junsik; Lee, Yong Jae; Nam, Eun Ji; Kim, Sang Wun; Kim, Sung-Hoon; Kim, Young Tae; Kim, Se Ik; Kim, Jae-Weon; Kim, Byoung-Gie; Lee, Jung-Yun

Phase II randomized study of first-line carboplatin and paclitaxel in combination with pembrolizumab, followed by maintenance pembrolizumab alone or with nesuparib, in mismatch-repair proficient, advanced or recurrent endometrial cancer (PENELOPE)

一项 II 期随机研究,评估一线卡铂和紫杉醇联合帕博利珠单抗治疗,随后单独使用帕博利珠单抗或联合奈舒帕利维持治疗,用于错配修复功能正常的晚期或复发性子宫内膜癌(PENELOPE)。

Kim, Se Ik; Cho, Hyun-Woong; Choi, Chel Hun; Park, Jeong-Yeol; Lee, Jung Bok; Kim, Jae-Weon; Kim, Byoung-Gie; Kim, John; Lee, Jung-Yun

Comparison of Active Knee Flexion Angles With and Without Tibiofemoral Joint Rotation Control Between Individuals With and Without Patellofemoral Pain Syndrome

比较有无髌股关节疼痛综合征患者在有无胫股关节旋转控制情况下的主动膝关节屈曲角度

Park, Ju-Hee; Gwak, Gyeong-Tae; Hwang, Ui-Jae; Weon, Jong-Hyuck; Kwon, Oh-Yun

Updated clinical practice guidelines for human papillomavirus vaccination: the Korean Society of Gynecologic Oncology recommendations

更新的人乳头瘤病毒疫苗接种临床实践指南:韩国妇科肿瘤学会的建议

Lim, Hyunji; Kim, Se Ik; Min, Kyung-Jin; Lee, Jae-Kwan; Kim, Jae-Weon; Lee, Taek Sang

Sexual Health and Quality of Life in Patients With Low-Risk Early-Stage Cervical Cancer: Results From GCIG/CCTG CX.5/SHAPE Trial Comparing Simple Versus Radical Hysterectomy

低危早期宫颈癌患者的性健康和生活质量:GCIG/CCTG CX.5/SHAPE试验比较单纯子宫切除术与根治性子宫切除术的结果

Ferguson, Sarah E; Brotto, Lori A; Kwon, Janice; Samouelian, Vanessa; Ferron, Gwenael; Maulard, Amandine; Kroon, Cor de; Driel, Willemien Van; Tidy, John; Williamson, Karin; Mahner, Sven; Kommoss, Stefan; Goffin, Frederic; Tamussino, Karl; Eyjolfsdottir, Brynhildur; Kim, Jae-Weon; Gleeson, Noreen; Tu, Dongsheng; Shepherd, Lois; Plante, Marie

Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results

奥拉帕尼治疗与非铂类化疗治疗铂敏感复发性卵巢癌患者的疗效比较:III期SOLO3研究最终总生存期结果

Scambia, Giovanni; Villalobos Valencia, Ricardo; Colombo, Nicoletta; Cibula, David; Leath, Charles A 3rd; Bidziński, Mariusz; Kim, Jae-Weon; Nam, Joo Hyun; Madry, Radoslaw; Hernández, Carlos; Mora, Paulo A R; Ryu, Sang Young; Ah-See, Mei-Lin; Lowe, Elizabeth S; Lukashchuk, Natalia; Carter, Dave; Penson, Richard T

Durvalumab versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): A Multicenter, Randomized, Phase 2 Trial

Durvalumab 与医生选择的化疗方案治疗复发性卵巢透明细胞腺癌 (MOCCA/APGOT-OV2/GCGS-OV3):一项多中心、随机、II 期试验

Ngoi, Natalie Y L; Choi, Chel Hun; Zhu, Junxian; Lim, Diana; Tan, Tuan Zea; Sun, Haoyang; Heong, Valerie; Ow, Samuel G W; Chay, Wen Yee; Kim, Hee Seung; Lim, Yi Wan; Lim, Siew Eng; Goss, Geraldine; Goh, Jeffrey C; Kim, Jae-Weon; Friedlander, Michael; Tai, Bee Choo; Kim, Kidong; Tan, David S P

A phase 1b, multicentre, dose escalation, safety and pharmacokinetics study of tilvestamab (BGB149) in relapsed, platinum-resistant, high-grade serous ovarian cancer (PROC) patients

一项针对复发性、铂耐药性、高级别浆液性卵巢癌 (PROC) 患者的 tilvestamab (BGB149) 的 1b 期多中心剂量递增、安全性和药代动力学研究

Sooi, Kenneth; Tan, Tuan Zea; Kim, Jae-Weon; Lee, Jung Yun; Kim, Byoung-Gie; Micklem, David; Jackson, Akil; Pinato, David J; Gourley, Charlie; Kristeleit, Rebecca; Blagden, Sarah P; Bjorge, Line; Tan, David Shao Peng

Asian Society of Gynecologic Oncology (ASGO) 2024 Annual Meeting in Bali, Indonesia

亚洲妇科肿瘤学会 (ASGO) 2024 年年会将于印度尼西亚巴厘岛举行。

Anggraeni, Tricia Dewi; Tjokroprawiro, Brahmana Askandar; Kim, Jae-Weon; Park, Jeong-Yeol

Developing standardized informed consent for hysterectomy and vulva cancer surgery

制定子宫切除术和外阴癌手术的标准化知情同意书

Oh, Soohyun; Lee, Geonwoo; Lee, Kwang-Beom; Kyung, Min-Sun; Kim, Myounghwan; Kim, Mi-Kyung; Bae, Jaeman; Song, Min Jong; Yoo, Heon Jong; Lee, Dae-Hyung; Lee, Sang-Hun; Chang, Ha Kyun; Kim, Jae-Weon; Park, Sang-Yoon